Back to results
US 2026/0076979 A1Published application
Composition for the treatment of covid-19
OwnerAlbert Nguyeninventor
Life of this patent
Estimating the term…
Abstract
A composition for the treatment of COVID-19 is disclosed, including a first composition including approximately 10 mg of dexamethasone. The first composition is combined with a second composition including between approximately 48 mg to approximately 80 mg of triamcinolone acetonide, sodium chloride, benzyl alcohol, carboxymethylcellulose sodium, and polysorbate 80.
Claims19
A composition for the treatment of COVID-19, comprising:
- an effective amount a first compound, the first compound comprising an effective amount of dexamethasone comprising approximately 10 mg of dexamethasone;
- and
- an effective amount of a second compound, the second compound comprising an effective amount of triamcinolone acetonide comprising approximately 40 mg to 80 mg of triamcinolone acetonide,
- wherein the effective amount of dexamethasone and the effective amount of triamcinolone acetonide are administered via injection once per day.
1 more element
A method for the treatment of COVID-19, the method comprising the steps of:
- forming a first composition, comprising:
- approximately 10 mg of dexamethasone;
- and forming a second composition comprising approximately 48 mg to approximately 80 mg of the following:
- approximately 48 mg to approximately 80 mg of triamcinolone acetonide;
- sodium chloride;
- benzyl alcohol;
- carboxymethylcellulose sodium;
- and
- polysorbate 80;
- drawing the first composition into a 3 ml syringe;
- drawing the second composition into the 3 ml syringe;
- and
- injecting the combined composition from the syringe into a patient.
10 more elements
Dependencies are inferred from the claim text.